Vice President, Biomarker & BioAnalytical Sciences
Sangamo Therapeutics
Richmond, California
Dr. Yanmei Lu is the Vice President of Biomarker and BioAnalytical Sciences at Sangamo Therapeutics, where she spearheads biomarker strategy, bioanalysis, and companion diagnostic development to advance gene and cell therapy programs across preclinical and clinical stages. Before joining Sangamo, Dr. Lu gained extensive experience at Genentech, developing pharmacokinetic (PK), biomarker, immunogenicity, and functional assays for antibody screening, candidate selection, and in vivo studies. Her work supported the evaluation of PK/PD, efficacy, and safety for large-molecule therapeutics in neuroscience, immunology, oncology, and ophthalmology.
Dr. Lu earned her PhD in Biochemistry and Molecular Biology from the University of South Florida and has authored over 50 peer-reviewed articles and book chapters. She is the editor and author of the Amazon bestseller Drug Development for Gene Therapy: Translational Biomarkers, Bioanalysis, and Companion Diagnostics.
Disclosure information not submitted.
Wednesday, November 12, 2025
1:30 PM - 2:30 PM CT